Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. The Senior Director, CMC Project Management is responsible for leading and coordinating the strategic planning, integration, and execution of the company’s CMC development programs across the portfolio. This role serves as the central program leadership function within Technical Operations and Quality Assurance, driving cross-functional alignment, integrated planning, and disciplined execution from early development through clinical and commercial milestones. Reporting to the Chief Technical Operations & Quality Officer, this individual will partner closely with Technical Operations, Regulatory, Quality, Clinical, and Finance to ensure CMC programs are delivered on time, within scope, and aligned with corporate objectives. This role is best suited for a strong program leader with deep experience in CMC project management, governance, and cross-function team leadership in a matrixed biotech environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior